Q2 2026 Vireo Growth Inc Earnings Call Transcript
Key Points
- Vireo Growth Inc (VREOF) reported strong Q2 2026 financial performance with GAAP revenue of $209.3 million, a 335% year-over-year increase, and pro forma revenue exceeding $1 billion annualized.
- The company is executing a differentiated growth strategy, expanding its platform through strategic acquisitions like Fluent, C21, Planet 13, and Ohio entry, positioning it as a leading multi-state operator with over 100 dispensaries in Florida.
- Vireo Growth Inc (VREOF) maintains a disciplined capital allocation approach, focusing on quality assets and strong operators, with a decentralized operating model that supports speed, flexibility, and local market knowledge.
- The company ended the quarter with $122.7 million in cash and cash equivalents, providing significant financial flexibility, and secured a new asset-based lending facility with Bank of Montreal at an industry-leading rate.
- Cannabis segment adjusted gross margin improved to 53%, up 120 basis points year-over-year, and adjusted EBITDA reached $41.5 million, reflecting operational optimization and integration success.
- Vireo Growth Inc (VREOF) is building a diversified cannabis and agribusiness platform, with non-cannabis segments like Hawthorne and Bridgewell contributing to supply chain capabilities and agricultural market exposure.
- The company's pro forma retail revenue growth of 7% year-over-year indicates strong same-store sales performance, particularly in markets where integration is complete.
- Vireo Growth Inc (VREOF) is one of the most under-levered companies in cannabis, avoiding the over-leverage issues seen in other industry players, and is buying at right multiples.
- The company expects to operate approximately 270 dispensaries across 15 states upon completion of pending transactions, creating one of the industry's broadest retail footprints.
- Management is focused on building $100 million-plus revenue businesses in each core state, with a clear long-term objective of generating non-volatile free cash flow.
- Adjusted EBITDA margin declined 790 basis points to 19.8% of sales, driven by the addition of the non-cannabis segment and recently acquired cannabis operations with historically lower margins.
- Gross margin declined 430 basis points to 47%, primarily due to the structurally lower margin profile of the non-cannabis segment, which carries an 18% adjusted gross margin.
- The company reported a net loss of $0.1 million for the quarter, although significantly improved from a $14.9 million loss in the prior year.
- Cannabis adjusted EBITDA margin decreased to 22.4% from 27.7% in the year-ago period, reflecting margin pressure from recent acquisitions and market dynamics.
- The non-cannabis segment's adjusted EBITDA margin is only 6.3%, indicating lower profitability in the agribusiness operations.
- Management acknowledged that achieving 7% same-store sales growth in perpetuity is not realistic for a platform with 270 dispensaries, suggesting potential slowdown in organic growth.
- The company faces execution risks associated with integrating multiple acquisitions, including Fluent, Planet 13, and Ohio transactions, which are pending regulatory approvals.
- Colorado, a mature market, is expected to maintain around 20% margins, which could be a long-term equilibrium, potentially limiting margin expansion in that state.
- The company's aggressive expansion strategy may lead to increased complexity and operational challenges, despite the decentralized model.
- Vireo Growth Inc (VREOF) is exposed to regulatory uncertainties, including potential interstate commerce changes, which could impact its state-specific strategy.
( Operators Instructions )
I will now hand the conference over to John Mazarakis, CEO. John, please go ahead.
Thank you, operator, and good morning everyone. The second quarter was another important step forward for Vireo. We delivered strong financial performance while continuing to execute against what we believe is one of the most differentiated growth strategies in the cannabis industry.
Tyson will review our financial results in a moment, but first I'd like to discuss our progress, our expanding platform and then spend a few minutes discussing the strategy that's driving these investments.
We closed several important transactions over the last few months, including Ease, Hawthorne and the Bridgewell Agribusiness. In addition, we announced several transformative transactions during the second quarter that should significantly expand our platform, including the acquisition of Fluent to expand and deepen in Florida, C21 to broaden our Nevada presence with a strong operator, and Planet 13 that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
